Morgan Stanley »

Theravance Biopharma shares owned by Morgan Stanley

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-06-30 $3.9M 459k 8.48
2024-03-31 $3.8M 419k 8.97
2023-12-31 $3.0M 263k 11.24
2023-09-30 $2.2M 253k 8.63
2023-06-30 $2.3M 223k 10.35
2022-12-31 $5.5M 488k 11.22
2022-06-30 $3.9M 394k 9.90
2022-03-31 $0 670k 0.00
2021-06-30 $6.5M 448k 14.46
2020-12-31 $11M 590k 17.76
2020-09-30 $1.8M 122k 14.80
2020-06-30 $8.4M 403k 20.99
2020-03-31 $13M 548k 23.11
2019-12-31 $16M 605k 25.90
2019-09-30 $9.8M 504k 19.48
2019-03-31 $16M 687k 22.67
2018-12-31 $16M 626k 25.59
2018-09-30 $3.8M 118k 32.67
2018-06-30 $0 102k 0.00
2018-03-31 $2.5M 102k 24.25
2017-12-31 $2.7M 96k 27.89
2017-03-31 $2.5M 67k 36.82
2016-12-31 $3.9M 123k 31.88
2016-09-30 $879k 27k 32.26
2016-06-30 $745k 33k 22.70
2016-03-31 $142k 7.8k 18.21
2015-12-31 $100k 6.0k 16.64
2015-09-30 $0 5.5k 0.00
2015-06-30 $281k 22k 13.01
2014-12-31 $2.6M 176k 14.92
2014-09-30 $2.2M 95k 23.05
2014-06-30 $222k 6.7k 32.97